GLIS2 and acute myeloid leukemia: Although the study did not show an impact of concomitant mutations on the outcome of CBFA2T3::GLIS2-positive AML patients, it unequivocally showed lower OS and EFS rates in patients with the fusion than in those without it, with the worst prognosis in infants (Table 4) [12].